Remove 2028 Remove Clinical Research Remove Treatment Remove Trials
article thumbnail

Article FDA Thank You The FDA rejected a psychedelic sponsor’s bid for approval. Here are six industry takeaways

Agency IQ

FDA released a draft guidance in June 2023 attempting to address many of these unique aspects of clinical research on psychedelic substances. Many commenters took issue with the guidance’s statement that, “The contribution of the psychotherapy component to any efficacy observed with psychedelic treatment has not been characterized.

FDA 40
article thumbnail

How AI in pharma can live up to the hype 

Drug Discovery World

With the advent of natural language processing, algorithms can now also contextualise these data and, combined with trend analysis, can guide researchers towards areas more likely to show promising treatments. . Which areas of drug discovery research stand to benefit most? . billion in 2021, an increase of 79% from 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA’s LDT Proposal and Its Impact on Clinical and Regulatory Professionals

The Premier Consulting Blog

Clinical development experts would need to navigate the potential complexities arising from this regulatory shift, particularly in terms of trial design and evidence generation. Our team is helping clients navigate the changing regulations and clinical research.

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

Until about 25 years ago, the best treatment option for someone with blood cancer was either toxic radiation and chemotherapy or a bone marrow transplant that posed additional life-threatening risks to the patient 1. Next, the advent of antibody treatments in 1997 created the first targeted cancer therapy 2.

Therapies 246